Do Thyroid Antibodies Cause Brain Inflammation in SREAT?
At a Glance
In SREAT, anti-TPO and anti-thyroglobulin antibodies are evidence of thyroid autoimmunity, but they are not proven to directly inflame or damage the brain. Antibody levels do not reliably measure symptom severity or recovery, so clinicians focus on symptoms and other tests.
In this answer
3 sections
It is understandable to fear that a high antibody number means ongoing damage to your brain, but current evidence does not support this. Anti-thyroid peroxidase (anti-TPO) and anti-thyroglobulin (anti-TG) antibodies are associated with autoimmune thyroid disease and are often used as part of the evaluation for Steroid-Responsive Encephalopathy Associated with Autoimmune Thyroiditis (SREAT, also known as Hashimoto’s encephalopathy). However, they are not proven to directly attack the brain [1][2]. Instead, the antibodies are supportive evidence of thyroid autoimmunity, but their presence alone does not establish SREAT or prove that they are the cause of your symptoms [1][2].
The Role of Thyroid Antibodies in Diagnosis
SREAT is a clinical diagnosis of exclusion, meaning doctors must first rule out other more common or treatable causes of encephalopathy (a general term for brain dysfunction), such as infections, metabolic issues, medication effects, or other types of autoimmune encephalitis [2]. While high thyroid antibodies are a clue that helps point toward SREAT, many people have these antibodies without ever developing neurological issues [1].
Although studies have sometimes detected low levels of thyroid antibodies in the cerebrospinal fluid (the fluid surrounding the brain and spinal cord) of SREAT patients, their presence there does not prove they are causing neuronal injury [3]. Some studies have found very low concentrations in the spinal fluid and no evidence that they actively cross the blood-brain barrier to cause damage [4].
Because these antibodies are simply markers of an autoimmune state, their levels in your blood do not reliably reflect the severity of your neurological symptoms [5][6]. A person can have very high antibody levels with mild symptoms, or lower levels with severe symptoms. Additionally, the level of anti-TPO or anti-TG does not reliably predict how well you will respond to corticosteroid treatments [7]. Therefore, doctors do not use antibody levels alone to diagnose SREAT or to monitor your recovery progress [5][7]. Monitoring your condition usually focuses on your clinical symptoms, cognitive function, and thyroid hormone status, rather than chasing the antibody number.
How Might SREAT Cause Neurologic Symptoms?
If the thyroid antibodies are not directly causing the damage, what is? The exact mechanism remains uncertain, and objective evidence of brain inflammation is not always present in SREAT. Researchers are exploring several hypotheses for how the condition might develop:
- T-Cell Driven Neuroinflammation: Some evidence suggests that certain immune cells, specifically T-cells, might drive inflammation in the nervous system [8][9].
- Molecular Mimicry: This theory proposes that the immune system might confuse specific proteins in the brain with thyroid proteins, leading to an unintended immune response [10].
- Blood-Brain Barrier Dysfunction: There is some indirect evidence that the protective barrier between the blood and the brain may become temporarily compromised, allowing inflammatory cells or proteins to enter [11].
Currently, these remain research theories rather than established facts [10][8][9]. The key takeaway is that a high antibody level is evidence of thyroid autoimmunity, not a direct measure of brain damage.
When to Seek Urgent Care
Because SREAT symptoms can fluctuate and overlap with other serious conditions, it is important not to attribute every new symptom to your antibodies. Seek urgent or emergency medical assessment if you experience sudden or severe confusion, a seizure, loss of consciousness, new weakness or speech difficulty, or rapidly worsening balance. These presentations require immediate evaluation to rule out other emergencies, such as infections or strokes, and should not be self-managed.
Common questions in this guide
Do thyroid antibodies directly attack the brain in SREAT?
Does a higher thyroid antibody level mean that SREAT symptoms will be worse?
Can positive thyroid antibodies by themselves diagnose SREAT?
What might cause neurological symptoms in SREAT if the antibodies are not directly damaging the brain?
When should I seek urgent care for possible SREAT symptoms?
Related questions
Show more
Get notified when new evidence is published on Steroid-responsive encephalopathy associated with autoimmune thyroiditis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (11)
- 1
Hashimoto's Encephalopathy: Case Series and Literature Review.
Chaudhuri J, Mukherjee A, Chakravarty A
Current neurology and neuroscience reports 2023; (23(4)):167-175 doi:10.1007/s11910-023-01255-5.
PMID: 36853554 - 2
Brain dysfunction and thyroid antibodies: autoimmune diagnosis and misdiagnosis.
Valencia-Sanchez C, Pittock SJ, Mead-Harvey C, et al.
Brain communications 2021; (3(2)):fcaa233 doi:10.1093/braincomms/fcaa233.
PMID: 34061124 - 3
Steroid-responsive encephalopathy associated with autoimmune thyroiditis (SREAT): Characteristics, treatment and outcome in 251 cases from the literature.
Laurent C, Capron J, Quillerou B, et al.
Autoimmunity reviews 2016; (15(12)):1129-1133 doi:10.1016/j.autrev.2016.09.008.
PMID: 27639840 - 4
Thyroid Autoantibodies in the Cerebrospinal Fluid of Subjects with and without Thyroid Disease: Implications for Hashimoto's Encephalopathy.
Ilias I, Karagiorga V, Paraskevas G, et al.
Journal of thyroid research 2015; (2015()):819072 doi:10.1155/2015/819072.
PMID: 26798549 - 5
Encephalopathy Associated with Autoimmune Thyroid Disease: A Potentially Reversible Condition.
Correia I, Marques IB, Ferreira R, Sousa L
Case reports in medicine 2016; (2016()):9183979 doi:10.1155/2016/9183979.
PMID: 27127515 - 6
Hashimoto encephalopathy in pediatric patients: Homogeneity in clinical presentation and heterogeneity in antibody titers.
Lee J, Yu HJ, Lee J
Brain & development 2018; (40(1)):42-48 doi:10.1016/j.braindev.2017.07.008.
PMID: 28784301 - 7
Hashimoto encephalopathy in the 21st century.
Mattozzi S, Sabater L, Escudero D, et al.
Neurology 2020; (94(2)):e217-e224 doi:10.1212/WNL.0000000000008785.
PMID: 31882532 - 8
Patients with a relapsing course of steroid-responsive encephalopathy associated with autoimmune thyroiditis exhibit persistent intrathecal CD4+ T-cell activation.
Pfeuffer S, Ruck T, Rolfes L, et al.
European journal of neurology 2021; (28(4)):1284-1291 doi:10.1111/ene.14657.
PMID: 33230897 - 9
HMGB1 dysregulation: a neuroimmune bridge to cognitive impairment in autoimmune thyroiditis.
Wang J, Chu G, Ding L, et al.
Frontiers in immunology 2026; (17()):1764288 doi:10.3389/fimmu.2026.1764288.
PMID: 41782877 - 10
Amino acid sequence homology between thyroid autoantigens and central nervous system proteins: Implications for the steroid-responsive encephalopathy associated with autoimmune thyroiditis.
Benvenga S, Antonelli A, Fallahi P, et al.
Journal of clinical & translational endocrinology 2021; (26()):100274 doi:10.1016/j.jcte.2021.100274.
PMID: 34849350 - 11
An observational study on the association of anti-thyroid autoantibodies with clinical, EEG, MRI, FDG-PET, cerebrospinal fluid and anti-neuronal antibody findings in 530 patients with schizophreniform and affective disorders.
Endres D, Runge K, Meixensberger S, et al.
Psychoneuroendocrinology 2021; (131()):105320 doi:10.1016/j.psyneuen.2021.105320.
PMID: 34171794
This page is for informational purposes only and does not constitute medical advice. Your neurologist and other clinicians should interpret thyroid antibody results and neurological symptoms in the context of your individual evaluation.